By: Benzinga
January 04, 2013 at 10:15 AM EST
UPDATE: Piper Jaffray Downgrades Endo Health Solutions to Neutral, Lowers PT
In a report published Friday, Piper Jaffray & Co. downgraded its rating on Endo Health Solutions (NASDAQ: ENDP ) from Overweight to Neutral, and lowered its price target from $37.00 to $28.00. Piper Jaffray noted, “We are downgrading Endo to a Neutral from an Overweight and lowering our price target
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here